This review examines the role of complement activation in acute kidney injury. The authors note that clinical evidence in many acute kidney injury settings remains largely associative. They found that the relative contribution of this mechanism varies across different causes of the injury. Complement activation represents a potential convergent mechanism of injury rather than a universally causal one.
The study provides an integrative framework for biomarker-guided stratification and precision therapy in acute kidney injury. This approach could help tailor treatments based on specific biological markers. However, the review highlights that more research is needed to fully understand these mechanisms.
Readers should understand that this evidence is associative rather than proving direct causation. The findings suggest a contributory role for complement activation but do not confirm it as the sole cause. This information helps guide future research and potential therapeutic strategies for patients with acute kidney injury.